#phase 2/3 trials

1 story

#biontech #business #cash reserves #money #oncology #pivotal data #se

BioNTech SE Shifts Focus
BioNTech SE pivots from pandemic vaccines to oncology with $19B cash and 33 trials.
Seekingalpha · 1m